Aim: This guideline is aimed at providing a reference for the pharmacological and non-pharmacological treatment of type 2 diabetes in adults. Methods: These recommendations apply to outpatients, either in primary care or at specialist referral. Prior cardio- vascular events, heart failure, renal disease, hypoglycemic risk and other conditions affecting life expectancy have been considered as factors capable of modifying treatment strate- gies. The following areas have been assessed: therapeutic goals, nutritional therapy, physical exercise, educational programs, pharmacological treatment, glucose monitoring. This guideline has been developed following the methods described in the Manual of the National Guideline Sys- tem (http://www.snlg-iss.it). For each question, the panel nominated by the Società Italiana di Diabetologia (SID) and Associazione Medici Diabetologi (AMD) identified poten- tially relevant outcomes, which were then rated for their impact on therapeutic choices. Only outcomes classified as “critical” were considered in the systematic review of evi- dence and in the formulation of recommendations. Results: The present guideline contains recommendations on the following clinical aspects of type 2 diabetes: 1) treat- ment targets; 2) nutritional therapy; 3) physical exercise; 4) educational therapy; 5) pharmacological treatment (for patients with and without previous cardiovascular disease); and 6) glycemic monitoring. Conclusions: The present guideline is directed to physi- cians, nurses, dietitians and educators working in Diabetes specialist clinics; general practitioners; nurses and dietitian working in territorial services or private offices; and patients with diabetes.

Italian guidelines for the treatment of type 2 diabetes

Candido, Riccardo;
2022-01-01

Abstract

Aim: This guideline is aimed at providing a reference for the pharmacological and non-pharmacological treatment of type 2 diabetes in adults. Methods: These recommendations apply to outpatients, either in primary care or at specialist referral. Prior cardio- vascular events, heart failure, renal disease, hypoglycemic risk and other conditions affecting life expectancy have been considered as factors capable of modifying treatment strate- gies. The following areas have been assessed: therapeutic goals, nutritional therapy, physical exercise, educational programs, pharmacological treatment, glucose monitoring. This guideline has been developed following the methods described in the Manual of the National Guideline Sys- tem (http://www.snlg-iss.it). For each question, the panel nominated by the Società Italiana di Diabetologia (SID) and Associazione Medici Diabetologi (AMD) identified poten- tially relevant outcomes, which were then rated for their impact on therapeutic choices. Only outcomes classified as “critical” were considered in the systematic review of evi- dence and in the formulation of recommendations. Results: The present guideline contains recommendations on the following clinical aspects of type 2 diabetes: 1) treat- ment targets; 2) nutritional therapy; 3) physical exercise; 4) educational therapy; 5) pharmacological treatment (for patients with and without previous cardiovascular disease); and 6) glycemic monitoring. Conclusions: The present guideline is directed to physi- cians, nurses, dietitians and educators working in Diabetes specialist clinics; general practitioners; nurses and dietitian working in territorial services or private offices; and patients with diabetes.
File in questo prodotto:
File Dimensione Formato  
s00592-022-01857-4.pdf

accesso aperto

Tipologia: Documento in Versione Editoriale
Licenza: Creative commons
Dimensione 1.05 MB
Formato Adobe PDF
1.05 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/3055006
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 17
social impact